Discovery of Potent and Selective Reversible Ubiquitin-Like Modifier Activating Enzyme 5 Inhibitors Targeting the UFMylation Pathway
Year: 2025
Type: article
Source: Journal of Medicinal Chemistry
Authors: James J. Mignone, Elizabeth A. Jurica, Deepa Rajasekaran, Jaclyn Robustelli, Courtney McCarthy, Phong Q. Quang, Qi Guo, Darby J. Ball, Andrew F. Donnell, Brian P. Mahon, Dawn Mulligan, Steven A. Spronk, Shivangi Srivastava, Erik C. Vik, Cullen L. Cavallaro, Farya J. Chattergoon, Bruce A. Ellsworth, Shriya Joshi, Emma Lees, R. Michael Lawrence, Ling Li, Selyna Mai, Mohammad K. Manik, Frank Marsilio, Konstantinos Mavrakis, Paramasivam Murugan, John A. Newitt, Payal Sheth, Jeffrey Tredup, Sarah C. Traeger, David D. Weis, Chunhong Yan, Joseph Yanchunas, Ping Zhang, Stephen T. Wrobleski, Peter Kalev, Joanne J. Bronson
Language: English
Subfield: Molecular Biology
Domain: Life Sciences
Open Access status: closed
OpenAlex ID: W4414517733
